nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An evaluation of the potential cost reductions resulting from the use of clodronate in the treatment of metastatic carcinoma of the breast to bone
|
Biermann, W.A. |
|
1991 |
12 |
S1 |
p. S37-S42 6 p. |
artikel |
2 |
Clinical consequences of osteolytic bone metastases
|
Namer, M. |
|
1991 |
12 |
S1 |
p. S7- 1 p. |
artikel |
3 |
Clodronate: The potential for the future
|
Powles, T. |
|
1991 |
12 |
S1 |
p. S43-S44 2 p. |
artikel |
4 |
Editorial Board
|
|
|
1991 |
12 |
S1 |
p. IFC- 1 p. |
artikel |
5 |
Incidence, prevalence and distribution of bone metastases
|
Tubiana-Hulin, M. |
|
1991 |
12 |
S1 |
p. S9-S10 2 p. |
artikel |
6 |
Management of breast cancer with bone metastases
|
Clavel, M. |
|
1991 |
12 |
S1 |
p. S11-S12 2 p. |
artikel |
7 |
Mechanisms of osteolytic bone destruction
|
Mundy, G.R. |
|
1991 |
12 |
S1 |
p. S1-S6 6 p. |
artikel |
8 |
New French studies of clodronate in cancer-induced osteolysis
|
Burki, F. |
|
1991 |
12 |
S1 |
p. S35- 1 p. |
artikel |
9 |
Rationale for the use of bisphosphonates in bone metastases
|
Kanis, J.A. |
|
1991 |
12 |
S1 |
p. S13-S18 6 p. |
artikel |
10 |
The use of clodronate in multiple myeloma
|
Delmas, P.D. |
|
1991 |
12 |
S1 |
p. S31-S34 4 p. |
artikel |
11 |
Treatment of hypercalcaemia of malignancy with clodronate
|
Bonjour, J-P. |
|
1991 |
12 |
S1 |
p. S19-S23 5 p. |
artikel |
12 |
Treatment of skeletal disease in breast cancer with clodronate
|
Paterson, A.H.G. |
|
1991 |
12 |
S1 |
p. S25-S30 6 p. |
artikel |